Dr. Michael Hogin Lovelace, MD

Dr. Lovelace practices at Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care.

Dr. Lovelace's NPI, 1679504476, was assigned on July 6, 2006. Dr. Lovelace graduated from University of Mississippi School of Medicine in 1980. Dr. Lovelace holds Mississippi license 09150.

Dr. Lovelace's primary practice is Baptist Memorial Hospital-North Mississippi, at 1100 Belk Blvd, Oxford, MS 38655 in Lafayette County. The practice phone is (662) 232-8100.

Dr. Lovelace's primary practice is Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care. Dr. Lovelace is also affiliated with Baptist Memorial Hospital-Union County. The medical group on file is The Surgery Consultants of Oxford, P.A. Dmand AI also links Dr. Lovelace to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lovelace practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Lovelace's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Lovelace is licensed in Mississippi.

CMS data shows 1,019 Medicare services from Dr. Lovelace across 6 procedure codes in 2024, for 172 Medicare patients. Medicare paid $44,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Lovelace in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lovelace's median patient age at 72, with 39% women.

In 2024, Dr. Lovelace wrote 114 Medicare Part D claims for 51 patients. 92% of them were for generic drugs. CMS names the drug for 53 of them, across 3 drugs with 11 or more claims each, at $320 in total drug cost. In 2023, CMS named 131 claims across 5 drugs.

Dr. Lovelace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 536 procedures of removal of tissue by Dr. Lovelace, more than 97% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 14 general payments to Dr. Lovelace from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 48% of the total. Endologix, Inc. paid the most, $768.

Dr. Lovelace graduated from University of Mississippi School of Medicine in 1980.